Author

R.A. Hannon

Observed names: R A Hannon, R Hannon, R. A. Hannon, R. Hannon, R.A Hannon, ROSEMARY A. HANNON, Rosemary A Hannon, Rosemary A. Hannon, Rosemary Hannon

Observed institutions: AstraZeneca (United Kingdom), University of Alberta, Stellenbosch University, University of Michigan, Mount Vernon Hospital, Northern General Hospital, Weston Park Cancer Centre, Nottingham City Hospital, University of Manchester, Royal Victoria Hospital, The Christie Hospital, Cross Cancer Institute, University of Glasgow, University of Sheffield

OpenAlex ID: A5111653903

Effect of Anastrozole on Bone Mineral Density: 5-Year Results From the Anastrozole, Tamoxifen, Alone or in Combination Trial 18233230

2008 · Richard Eastell, Judith E. Adams, et al. · Journal of Clinical Oncology · 417

Effect of an Aromatase Inhibitor on BMD and Bone Turnover Markers: 2-Year Results of the Anastrozole, Tamoxifen, Alone or in Combination (ATAC) Trial (18233230)

2006 · Richard Eastell, Rosemary A Hannon, et al. · Journal of Bone and Mineral Research · 332

Effect of feeding on bone turnover markers and its impact on biological variability of measurements

2002 · J.A Clowes, R.A Hannon, et al. · Bone · 305

Response of Biochemical Markers of Bone Turnover to Hormone Replacement Therapy: Impact of Biological Variability

1998 · Rosemary Hannon, Aubrey Blumsohn, et al. · Journal of Bone and Mineral Research · 257

Preanalytical Variability of Biochemical Markers of Bone Turnover

2000 · R. Hannon, R. Eastell · Osteoporosis International · 245

Prevention of Aromatase Inhibitor–Induced Bone Loss Using Risedronate: The SABRE Trial

2010 · Catherine Van Poznak, Rosemary A. Hannon, et al. · Journal of Clinical Oncology · 228

Biomarkers of bone health and osteoporosis risk

2008 · Richard Eastell, Rosemary A. Hannon · Proceedings of The Nutrition Society · 220

PDF

Biochemical markers of bone turnover in girls during puberty

1994 · A. Blumsohn, R. A. Hannon, et al. · Clinical Endocrinology · 205

Circulating Estradiol and Osteoprotegerin as Determinants of Bone Turnover and Bone Density in Postmenopausal Women

2002 · A. Rogers, G. Saleh, et al. · The Journal of Clinical Endocrinology & Metabolism · 202

Prevention of Anastrozole-Induced Bone Loss with Monthly Oral Ibandronate during Adjuvant Aromatase Inhibitor Therapy for Breast Cancer

2008 · James E. Lester, David Dodwell, et al. · Clinical Cancer Research · 189

Clinical performance of immunoreactive tartrate-resistant acid phosphatase isoform 5b as a marker of bone resorption

2003 · Rosemary A. Hannon, Jackie A. Clowes, et al. · Bone · 154

Effects of the Src kinase inhibitor saracatinib (AZD0530) on bone turnover in healthy men: A randomized, double-blind, placebo-controlled, multiple-ascending-dose phase I trial

2009 · Rosemary A Hannon, Glen Clack, et al. · Journal of Bone and Mineral Research · 109

PDF

Effects of third generation aromatase inhibitors on bone health and other safety parameters: Results of an open, randomised, multi-centre study of letrozole, exemestane and anastrozole in healthy postmenopausal women

2007 · Eugene V. McCloskey, Rosemary A. Hannon, et al. · European Journal of Cancer · 91

Effect of Stopping Risedronate after Long-Term Treatment on Bone Turnover

2011 · Richard Eastell, Rosemary A. Hannon, et al. · The Journal of Clinical Endocrinology & Metabolism · 89

Monitoring Alendronate Therapy for Osteoporosis

1999 · Adriana Braga De castro machado, Rosemary Hannon, et al. · Journal of Bone and Mineral Research · 89

Risk Factors for Vertebral and Nonvertebral Fracture Over 10 Years: A Population-Based Study in Women

2007 · Judith Finigan, Diana M Greenfield, et al. · Journal of Bone and Mineral Research · 78

Relationship of Early Changes in Bone Resorption to the Reduction in Fracture Risk With Risedronate: Review of Statistical Analysis

2007 · Richard Eastell, Rosemary A Hannon, et al. · Journal of Bone and Mineral Research · 77

PDF

Changes in bone mineral density, body composition and biochemical markers of bone turnover during weight gain in adolescents with severe anorexia nervosa: a 1-year prospective study

2005 · J. E. Compston, C. McConachie, et al. · Osteoporosis International · 72

Absence of Marked Seasonal Change in Bone Turnover: A Longitudinal and Multicenter Cross-Sectional Study

2003 · Aubrey Blumsohn, Kim E Naylor, et al. · Journal of Bone and Mineral Research · 72

Long-term effects of aromatase inhibitors on bone

2005 · Richard Eastell, Rosemary Hannon · The Journal of Steroid Biochemistry and Molecular Biology · 67

Bone mineral density and bone turnover in spinal osteoarthrosis.

1995 · N.F Peel, N.A Barrington, et al. · Annals of the Rheumatic Diseases · 66

PDF

Apparent instability of osteocalcin in serum as measured with different commercially available immunoassays

1995 · A Blumsohn, R A Hannon, et al. · Clinical Chemistry · 66

Risedronate in adults with osteogenesis imperfecta type I: increased bone mineral density and decreased bone turnover, but high fracture rate persists

2011 · L. A. Bradbury, S. Barlow, et al. · Osteoporosis International · 57

Changes in bone resorption and vascular endothelial growth factor after a single zoledronic acid infusion in cancer patients with bone metastases from solid tumours

2006 · Daniele Santini, Bruno Vincenzi, et al. · Oncology Reports · 52

PDF

Biochemical Markers of Bone Turnover and Fracture Prediction

2003 · Rosemary A Hannon, Richard Eastell · The Journal of the British Menopause Society · 41

Works count: 64

Citation count: 4,075

H-index: 28

I10-index: 36